Searchable abstracts of presentations at key conferences in endocrinology

ea0050p405 | Thyroid | SFEBES2017

Metoprolol succinate is associated with better quality of life in treatment of grave’s disease

Ghazi Hossam

Background: Grave’s Disease (GD) is the most common cause of hyperthyroidism and its effect of health status is well known. Beta blockers (BB) are routinely used to control thyrotoxic symptoms in initial phase of treatment of GD.Objective: To study the effect of BB on quality of life (QOL) in patients with GD using different BB; propranolol, nebivolol and metoprolol succinate.Method: A cohort prospective study was conducted on...

ea0050p405 | Thyroid | SFEBES2017

Metoprolol succinate is associated with better quality of life in treatment of grave’s disease

Ghazi Hossam

Background: Grave’s Disease (GD) is the most common cause of hyperthyroidism and its effect of health status is well known. Beta blockers (BB) are routinely used to control thyrotoxic symptoms in initial phase of treatment of GD.Objective: To study the effect of BB on quality of life (QOL) in patients with GD using different BB; propranolol, nebivolol and metoprolol succinate.Method: A cohort prospective study was conducted on...

ea0090p232 | Thyroid | ECE2023

Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy Vs Percutaneous Ethanol Injection in Benign Cystic Thyroid Nodules: Preliminary Results

Ghazi Hossam , Gouda Sherihan , Saleh Mayada , Harb Dina

Introduction: Percutaneous Ethanol Injection (PEI) is well known treatment for benign cystic thyroid nodules; however, local pain is common side effect. Objective: To compare between efficacy and safety of Percutaneous Polidocanol Sclerotherapy (PPS) vs PEI.Patients and methods: We included 60 patients -with mean age 32 years- have benign thyroid nodules (9 of them were males). They were divided into 2 groups; group 1 with...